These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 941742)

  • 41. Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.
    Andén NE; Svensson TH
    J Neural Transm; 1973; 34(1):23-30. PubMed ID: 4714591
    [No Abstract]   [Full Text] [Related]  

  • 42. Release of endogenous catecholamines from isolated rat brain tissue by fenfluramine and N-ethylamphetamine--effects of pargyline.
    Tessel RE; Burgess SK; Rutledge CO
    Biochem Pharmacol; 1978; 27(12):1631-6. PubMed ID: 697904
    [No Abstract]   [Full Text] [Related]  

  • 43. The accumulation of p-hydroxyamphetamine by brain homogenates and its role in the release of catecholamines.
    Cho AK; Fischer JF; Schaeffer JC
    Biochem Pharmacol; 1977 Aug; 26(15):1367-72. PubMed ID: 901551
    [No Abstract]   [Full Text] [Related]  

  • 44. Differential behavioural effects after subtotal depletions of dopamine or noradrenaline in the ventral striatum.
    Schwarting RK; Carey RJ
    Funct Neurol; 1988; 3(1):29-36. PubMed ID: 3134274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in neostriatal dopamine concentrations in response to levodopa infusions.
    Doller HJ; Connor JD
    J Neurochem; 1980 May; 34(5):1264-9. PubMed ID: 7373307
    [No Abstract]   [Full Text] [Related]  

  • 46. Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress.
    Lidbrink P; Corrodi H; Fuxe K; Olson L
    Brain Res; 1972 Oct; 45(2):507-24. PubMed ID: 4404488
    [No Abstract]   [Full Text] [Related]  

  • 47. Catecholamine concentration in discrete brain areas following the withdrawal of barbital dependent rats.
    Morgan WW; Pfeil KA; Gonzales EG
    Life Sci; 1977 Feb; 20(3):493-9. PubMed ID: 557159
    [No Abstract]   [Full Text] [Related]  

  • 48. Some characteristics of the 'functional' and 'main storage' compartments in central catecholaminergic neurons.
    Glowinski J
    Brain Res; 1973 Nov; 62(2):489-93. PubMed ID: 4128241
    [No Abstract]   [Full Text] [Related]  

  • 49. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
    Peters DA; Tang S
    J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
    [No Abstract]   [Full Text] [Related]  

  • 50. Quantified regional and laminar distribution of the noradrenaline innervation in the anterior half of the adult rat cerebral cortex.
    Audet MA; Doucet G; Oleskevich S; Descarries L
    J Comp Neurol; 1988 Aug; 274(3):307-18. PubMed ID: 2464617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of adaptive regulation in the pathophysiology of psychiatric disease.
    Mandell AJ
    J Psychiatr Res; 1974; 11():173-9. PubMed ID: 4142643
    [No Abstract]   [Full Text] [Related]  

  • 52. [Correlation of presynaptic components (uptake--release) in antidepressants].
    Dolzhenko AT
    Farmakol Toksikol; 1984; 47(5):22-5. PubMed ID: 6094236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 54. 6-Aminodopamine-induced degeneration of catecholamine neurons.
    Jonsson G; Sachs C
    J Neurochem; 1973 Jul; 21(1):117-24. PubMed ID: 4720890
    [No Abstract]   [Full Text] [Related]  

  • 55. Interaction between cholinergic and catecholaminergic neurones in rat brain.
    Corrodi H; Fuxe K; Lidbrink P
    Brain Res; 1972 Aug; 43(2):397-416. PubMed ID: 4403347
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of 6-hydroxydopamine and reserpine on amphetamine-induced release of norepinephrine in rat cerebral cortex.
    Kalisker A; Waymire JC; Rutledge CO
    J Pharmacol Exp Ther; 1975 Apr; 193(1):64-72. PubMed ID: 237115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex.
    Izenwasser S; Werling LL; Cox BM
    Brain Res; 1990 Jun; 520(1-2):303-9. PubMed ID: 2145054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effect of morphine on dopaminergic neurons in frontal cortex and striatum of the rat.
    Moleman P; Bruinvels J
    Life Sci; 1976 Oct; 19(8):1277-82. PubMed ID: 994726
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug-induced rotational behaviour following unilateral intracerebral injection of saline-ascorbate solution: neurotoxicity of ascorbic acid and monoamine-independent circling.
    Waddington JL; Crow TJ
    Brain Res; 1979 Feb; 161(2):371-6. PubMed ID: 310332
    [No Abstract]   [Full Text] [Related]  

  • 60. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
    Heikkila RE; Orlansky H; Mytilineou C; Cohen G
    J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.